News | January 09, 2026
Oculis’ Privosegtor wins FDA breakthrough therapy status for Optic Neuritis
The FDA designation follows visual-function results from the Phase 2 ACUITY trial
The FDA designation follows visual-function results from the Phase 2 ACUITY trial
Tiger Shroff fronts ‘Fit Raho, Hit Raho’ campaign
Sevabertinib is an oral, reversible tyrosine kinase inhibitor (TKI) that directly targets HER2 mutations
Within India, Dabur expects its Home & Personal Care business to deliver double-digit growth,
India’s traditional medicine systems have also earned formal recognition in key bilateral trade agreements
Syrma Johari is a globally recognised medical device engineering and manufacturing organisation
Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
Motiva, SmoothSilk, Round and Ergonomix implants represent the latest in plastic surgery innovation
Applications include detailed scientific rationale and supporting clinical evidence
Subscribe To Our Newsletter & Stay Updated
